News & Updates

Show Multimedia Only
Odronextamab plus chemo safe as DLBCL treatment, with promising efficacy
Odronextamab plus chemo safe as DLBCL treatment, with promising efficacy
16 Jan 2026
Maternal asthma may raise congenital heart defect risk in offspring
Maternal asthma may raise congenital heart defect risk in offspring
15 Jan 2026 byStephen Padilla

Asthma and allergic tendency in mothers appear to elevate the risk of congenital heart defect (CHD) in their children, suggests a study, noting that nonallergic asthma also contributes to such risk.

Maternal asthma may raise congenital heart defect risk in offspring
15 Jan 2026